Skip to content

4-[4-(3-phenylpropyl)piperazin-1-yl]-2-[(1S)-1-(1,3-thiazol-2-yl)ethyl]isoindole-1,3-dione

C26H28N4O2S — CID 26351747

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC4-[4-(3-phenylpropyl)piperazin-1-yl]-2-[(1S)-1-(1,3-thiazol-2-yl)ethyl]isoindole-1,3-dione
SMILESC[C@@H](c1nccs1)N1C(=O)c2cccc(N3CCN(CCCc4ccccc4)CC3)c2C1=O
InChIInChI=1S/C26H28N4O2S/c1-19(24-27-12-18-33-24)30-25(31)21-10-5-11-22(23(21)26(30)32)29-16-14-28(15-17-29)13-6-9-20-7-3-2-4-8-20/h2-5,7-8,10-12,18-19H,6,9,13-17H2,1H3/t19-/m0/s1
InChIKeyMSFKGLIREBQZPC-IBGZPJMESA-N
MW460.60 g/mol
LogP4.26
Rot. Bonds7

About 4-[4-(3-phenylpropyl)piperazin-1-yl]-2-[(1S)-1-(1,3-thiazol-2-yl)ethyl]isoindole-1,3-dione

4-[4-(3-phenylpropyl)piperazin-1-yl]-2-[(1S)-1-(1,3-thiazol-2-yl)ethyl]isoindole-1,3-dione (PubChem CID 26351747) has the molecular formula C26H28N4O2S and a molecular weight of 460.60 g/mol. Its IUPAC name is 4-[4-(3-phenylpropyl)piperazin-1-yl]-2-[(1S)-1-(1,3-thiazol-2-yl)ethyl]isoindole-1,3-dione.

Molecular Properties

Compound Name4-[4-(3-phenylpropyl)piperazin-1-yl]-2-[(1S)-1-(1,3-thiazol-2-yl)ethyl]isoindole-1,3-dione
PubChem CID26351747
Molecular FormulaC26H28N4O2S
Molecular Weight460.60 g/mol
Exact Mass460.19
IUPAC Name4-[4-(3-phenylpropyl)piperazin-1-yl]-2-[(1S)-1-(1,3-thiazol-2-yl)ethyl]isoindole-1,3-dione
SMILESC[C@@H](c1nccs1)N1C(=O)c2cccc(N3CCN(CCCc4ccccc4)CC3)c2C1=O
InChIInChI=1S/C26H28N4O2S/c1-19(24-27-12-18-33-24)30-25(31)21-10-5-11-22(23(21)26(30)32)29-16-14-28(15-17-29)13-6-9-20-7-3-2-4-8-20/h2-5,7-8,10-12,18-19H,6,9,13-17H2,1H3/t19-/m0/s1
InChIKeyMSFKGLIREBQZPC-IBGZPJMESA-N
XLogP4.26
TPSA56.75 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms33
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500460.60
LogP ≤ 54.26
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 4-[4-(3-phenylpropyl)piperazin-1-yl]-2-[(1S)-1-(1,3-thiazol-2-yl)ethyl]isoindole-1,3-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[4-(3-phenylpropyl)piperazin-1-yl]-2-[(1S)-1-(1,3-thiazol-2-yl)ethyl]isoindole-1,3-dione?
The IUPAC name of 4-[4-(3-phenylpropyl)piperazin-1-yl]-2-[(1S)-1-(1,3-thiazol-2-yl)ethyl]isoindole-1,3-dione (CID 26351747) is 4-[4-(3-phenylpropyl)piperazin-1-yl]-2-[(1S)-1-(1,3-thiazol-2-yl)ethyl]isoindole-1,3-dione.
What is the SMILES notation for 4-[4-(3-phenylpropyl)piperazin-1-yl]-2-[(1S)-1-(1,3-thiazol-2-yl)ethyl]isoindole-1,3-dione?
The canonical SMILES for 4-[4-(3-phenylpropyl)piperazin-1-yl]-2-[(1S)-1-(1,3-thiazol-2-yl)ethyl]isoindole-1,3-dione is C[C@@H](c1nccs1)N1C(=O)c2cccc(N3CCN(CCCc4ccccc4)CC3)c2C1=O.
What is the InChIKey of 4-[4-(3-phenylpropyl)piperazin-1-yl]-2-[(1S)-1-(1,3-thiazol-2-yl)ethyl]isoindole-1,3-dione?
The InChIKey is MSFKGLIREBQZPC-IBGZPJMESA-N. The full InChI is InChI=1S/C26H28N4O2S/c1-19(24-27-12-18-33-24)30-25(31)21-10-5-11-22(23(21)26(30)32)29-16-14-28(15-17-29)13-6-9-20-7-3-2-4-8-20/h2-5,7-8,10-12,18-19H,6,9,13-17H2,1H3/t19-/m0/s1.
What are the key properties of 4-[4-(3-phenylpropyl)piperazin-1-yl]-2-[(1S)-1-(1,3-thiazol-2-yl)ethyl]isoindole-1,3-dione?
4-[4-(3-phenylpropyl)piperazin-1-yl]-2-[(1S)-1-(1,3-thiazol-2-yl)ethyl]isoindole-1,3-dione has a molecular weight of 460.60 g/mol, XLogP of 4.26, 7 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[4-(3-phenylpropyl)piperazin-1-yl]-2-[(1S)-1-(1,3-thiazol-2-yl)ethyl]isoindole-1,3-dione is sourced from PubChem (CID 26351747), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.